Brought to you by 
Archemix gets $51.75mm in Series A round
03 Sep 2002
Executive Summary
Privately held Archemix Corp. (aptamer-based therapeutics) completed a $51.75mm Series A round private placement to lead investors Schroder Ventures Life Sciences, Atlas Venture, and Prospect Venture Partners. Also participating in the round were Rho Ventures, Care Capital, MDS Capital, Posco BioVentures, and US Trust Private Equity.
Deal Industry
- Pharmaceuticals
- Research, Analytical Equipment & Supplies
-
Biotechnology
- Antisense, Oligonucleotides
- Large Molecule
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Archemix gets $51.75mm in Series A round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice